Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

Non-atherosclerotic arterial diseases

Non-atherosclerotic arterial diseases comprise conditions in which arterial injury does not primarily arise from the formation of an atheromatous plaque. The term defines a heterogeneous group, not a single disease: abnormalities of the vessel wall, thromboinflammatory processes, extrinsic compression, traumatic lesions and changes in vascular tone can produce seemingly similar manifestations through different mechanisms. Identifying these mechanisms matters because a stenosis may call for angioplasty, surgical decompression, treatment of a systemic disease or no invasive procedure at all.

Suspicion increases when ischemia, renovascular hypertension or arterial abnormalities occur in a young person without the usual risk profile, or display an atypical anatomical distribution. However, age and the absence of smoking, diabetes or dyslipidemia are insufficient diagnostic criteria. Atherosclerosis may develop early, a non-atherosclerotic disorder may be discovered in an older person, and both may coexist. Clinical reasoning must link vascular structure, symptoms and context, rather than relying on age alone to classify the condition.

Some of these conditions mainly cause obstruction, others increase susceptibility to dissection and aneurysm, and still others reduce blood flow intermittently. Raynaud phenomenon belongs to the vasospastic group and, in its primary form, does not amount to a permanent structural arterial lesion. Distinguishing functional phenomena from organic damage is therefore essential to assessment and prevents the same degree of risk being attributed to all peripheral manifestations.

Main mechanisms and causes

Fibromuscular dysplasia is a non-inflammatory, segmental disease of the arterial wall that predominantly affects medium-sized arteries. Focal and multifocal forms may narrow the lumen; aneurysms, tortuosity and dissections may accompany the condition. Renal or cervicocephalic involvement shows that non-atherosclerotic arterial disease is not necessarily a disease of the legs. A finding in one arterial territory may have implications for assessing others.

Thromboangiitis obliterans, or Buerger disease, is instead closely associated with tobacco exposure and mainly affects small and medium-sized distal vessels, with thrombosis and an inflammatory component. Superficial venous involvement and manifestations in several limbs may occur. Not every case of digital ischemia in a smoker is Buerger disease: embolism, connective tissue disorders, diabetes, atherosclerosis and other causes must be considered before assigning this diagnosis.

Compressive disorders depend on the anatomical relationships between an artery and the surrounding structures. In popliteal artery entrapment syndrome, abnormal musculotendinous configurations or functional compression during muscle contraction play a role. Arterial thoracic outlet syndrome chiefly involves the subclavian artery and may be associated with bony abnormalities. Repeated mechanical conflict can turn a transient reduction in flow into a permanent lesion.

In cystic adventitial disease, narrowing results from mucinous collections in the outer arterial wall, often at the popliteal level. The lumen is compressed from outside rather than occupied by plaque. Endofibrosis in athletes, vibration injury and repeated hand trauma are also causes to consider in selected settings. These diagnoses require a precise history of sports-related or occupational stresses, not merely the observation that the patient engages in physical activity.

Vasculitis of large and medium-sized vessels, inherited arterial disorders and dissections further expand this spectrum. Wall inflammation, connective tissue fragility and separation of vascular layers can cause stenoses and dilatations, sometimes simultaneously. Non-atherosclerotic therefore does not mean non-inflammatory: that property applies to some conditions, not the whole category. Similarly, thrombosis is often the final result of a lesion but does not automatically reveal its cause.

Pathophysiology of impaired perfusion

A fixed stenosis reduces flow reserve before necessarily compromising perfusion at rest. The patient may experience pain only during exercise, when metabolic demand rises. Symptom location depends on the downstream territory and collateral supply, not just on where the stenosis lies. In the kidney, a significant reduction in perfusion pressure may activate hormonal mechanisms that maintain blood pressure; hypertension rather than ischemic pain may therefore dominate the clinical presentation.

Dynamic compression may disappear when the limb returns to a neutral position. Consequently, pulses, pressures and resting imaging may appear normal despite symptoms reproducibly triggered by a specific movement. Conversely, certain extreme manoeuvres also reduce flow in healthy individuals. Diagnosing a syndrome requires convincing agreement between the usual complaint, the haemodynamic change and the responsible structure: an isolated positive provocative test may lead to overdiagnosis and unnecessary intervention.

Endothelial injury caused by mechanical conflict or arterial wall abnormalities can promote local thrombosis and distal embolization. At this stage, changing posture no longer necessarily reverses the symptom: a lesion that was originally dynamic has acquired an organic component. An ischemic finger may be the distal sign of a proximal source that remains patent, while post-stenotic dilatation may become a reservoir of thrombus. Assessment must therefore trace the arterial axis proximally rather than stopping at the most painful site.

In vasospasm, excessive contraction of small arteries and arterioles predominates, often triggered by cold or stress. When the phenomenon is primary, attacks are reversible and should not cause tissue loss. In secondary forms, particularly those associated with connective tissue disease, structural microangiopathy can reduce reserve and make the transient decrease in flow more severe. The appearance of ulcers or necrosis therefore requires reassessment of the diagnosis, rather than being regarded as the normal progression of benign Raynaud phenomenon.

Clinical manifestations and history-taking

The time course of symptoms must establish onset, duration, triggers and recovery. Calf pain reproducibly occurring at a certain level of exertion suggests a different problem from sudden ischemia at rest; cold-induced colour change differs from persistent cyanosis of a single finger or toe. It is useful to ask whether symptoms depend on raising the arm, neck position, knee flexion or a specific sport, without suggesting answers that replace the patient's spontaneous account.

Exposures and medical history should be recorded: tobacco use, vasoconstrictor substances, medicines, vibration, trauma, arterial access procedures and surgery. Recurrent superficial thrombophlebitis, digital ulcers, unusual headache, pulsatile tinnitus, previous dissections and early-onset hypertension may guide the work-up. Fever, weight loss, joint pains, skin changes and ocular symptoms suggest the possibility of systemic disease. Family history should cover early arterial events and ruptures without automatically assuming Mendelian inheritance in every case.

The physical examination compares the limbs and includes pulses, temperature, colour, capillary refill, skin lesions, strength and sensation. Blood pressures are measured when a side-to-side difference may be informative, and bruits are sought at relevant sites. Hands and feet should also be examined for ischemic scars and tissue loss. A preserved proximal pulse does not exclude distal occlusion, whereas disappearance of a pulse during a manoeuvre does not, on its own, prove a pathological compression.

The presence of an acute motor or sensory deficit, persistent severe pain, a cold limb or rapidly progressing lesions calls for urgent assessment of tissue viability. The wish to identify a rare cause must not delay treatment of threatening ischemia. Likewise, new focal neurological symptoms, chest pain or acute abdominal pain in a patient with known arterial disease require an emergency pathway appropriate to the affected vascular territory, not merely an earlier outpatient review.

Investigations and differential diagnosis

Haemodynamic tests document whether the symptoms correspond to reduced perfusion. The ankle-brachial index, digital pressures and waveforms provide complementary information; post-exercise measurement may help when the resting value is normal. In the digits, ambient temperature and vasoconstriction can alter the result, which must be interpreted in light of the conditions under which it was obtained. None of these tests alone identifies dysplasia, entrapment or vasculitis: they describe the functional consequence requiring explanation.

Duplex Doppler ultrasound combines morphology and flow assessment and may include standardized dynamic manoeuvres. Stenosis without plaque, a collection within the vessel wall, dilatation containing thrombus or position-dependent compression point towards different diagnostic pathways. Reproducibility and comparison with the opposite limb are useful but do not replace correlation with the usual symptom. If the territory cannot be visualized adequately, an examination described simply as normal should not close a well-founded clinical suspicion.

CT angiography and MR angiography clarify the lumen, arterial wall and extravascular relationships. MRI may be particularly informative for musculotendinous structures and cystic components; CT depicts bone structures and arterial geometry well. Some syndromes require acquisitions in the position that produces the conflict, planned without relying on a single static image. Invasive angiography remains indicated when it changes treatment or provides information that cannot be obtained less invasively.

When secondary Raynaud phenomenon is suspected, nailfold capillaroscopy and targeted immunological investigations can identify microangiopathy or a connective tissue disorder. In other presentations, laboratory tests for inflammation, autoimmunity, infection or thrombophilia should answer a specific, clinically justified question. A broad panel ordered without a meaningful pretest probability yields nonspecific results that may confuse the diagnosis. Arterial biopsy is not a mandatory step for diseases diagnosed from their clinical phenotype and imaging findings.

The differential diagnosis also includes nonvascular disorders. Chronic exertional compartment syndrome, radiculopathy, peripheral neuropathies and osteoarticular disorders may mimic claudication or positional symptoms. Persistent acrocyanosis, chilblains and embolic ischemia must not automatically be equated with Raynaud phenomenon. A convincing evaluation must explain not only the imaging finding but also why it causes the observed symptoms and why the alternatives are less likely.

Disease characterization and choice of treatment

Further characterization distinguishes a local lesion from systemic arterial disease. An anatomical conflict may require assessment of the opposite side and distal runoff; documented dysplasia may justify more extensive vascular mapping; vasculitis requires assessment of disease activity and involved organs. Distal thrombosis requires a search for a possible proximal or cardiac source. The scope of investigation should be guided by the diagnosis, not turn into the same checklist of tests for everyone.

Treatment targets the causal mechanism. Persistent compression may require decompression with possible repair of the damaged artery; a stent placed without resolving the conflict remains exposed to the same forces. Simply correcting blood lipids does not eliminate an adventitial cyst. A haemodynamically significant dysplastic renal stenosis may be treated in selected patients, but not every angiographic irregularity requires dilatation. The intervention must have an explicit, realistic clinical objective.

In Buerger disease, complete tobacco cessation is central to controlling the disease and the risk of amputation. Cutting down is not the same as abstinence; support for nicotine dependence must be part of treatment. In confirmed vasculitis, treating inflammation may be essential, but corticosteroids and immunosuppressants are not a generic treatment for all non-atherosclerotic arterial diseases. Using them solely because a stenosis has no plaque may be ineffective or harmful.

Vasospastic forms require protection from cold, reduction of triggers and, when indicated, vasodilator medicines. Persistent digital lesions warrant a broader evaluation of perfusion, infection and the underlying disease. Antiplatelet agents, anticoagulants and statins are prescribed for defined indications, not because every arterial disorder should receive an atherosclerosis treatment regimen. In particular, the benefit of a drug in a common disease does not automatically establish efficacy in a rare form with a different pathogenesis.

Prognosis, complications and follow-up

Prognosis ranges from reversible phenomena without tissue damage to conditions capable of causing stroke, organ loss or amputation. Early diagnosis may prevent intermittent compression from becoming complicated by thrombosis, but not all asymptomatic anatomical abnormalities require surgery. Even after technically successful treatment, function may recover only partially if the distal vascular bed, nerves or tissues have sustained irreversible injury. Vessel patency and patient wellbeing are distinct outcomes, and both must be assessed.

The main complications are occlusion, embolization, trophic lesions, ulcer infection, dissection and aneurysmal dilatation in predisposed phenotypes. Recurrent compression, new stenosis and reconstruction-related problems may require imaging follow-up. After urgent revascularization, reperfusion injury and compartment syndrome must also be recognized. Young age does not protect patients from these consequences and must not lessen attention to the severity of clinical signs.

Individualized follow-up encompasses changes in symptoms, limb or organ function, ongoing exposures, adherence to treatment and imaging when useful. Follow-up frequency cannot be identical for primary Raynaud phenomenon, a reconstructed artery and multisite dysplasia. Patients must know the warning signs requiring prompt reassessment and receive physical activity advice proportionate to their particular lesion, avoiding both documented traumatic movements and broad restrictions without clinical justification.

References
  1. Gornik HL et al. First international consensus on the diagnosis and management of fibromuscular dysplasia. Journal of Hypertension. 2019;37(2):229-252.
  2. Olin JW. Thromboangiitis obliterans (Buerger’s disease). The New England Journal of Medicine. 2000;343(12):864-869.
  3. Le Joncour A et al. Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger’s Disease): A Multicenter Study of 224 Patients. Journal of the American Heart Association. 2018;7(23):e010677.
  4. Bradshaw S et al. Popliteal artery entrapment syndrome. Cardiovascular Diagnosis and Therapy. 2021;11(5):1159-1167.
  5. Maverakis E et al. International consensus criteria for the diagnosis of Raynaud’s phenomenon. Journal of Autoimmunity. 2014;48-49:60-65.
  6. Herrick AL. Evidence-based management of Raynaud’s phenomenon. Therapeutic Advances in Musculoskeletal Disease. 2017;9(12):317-329.
  7. Yaghi S et al. Treatment and Outcomes of Cervical Artery Dissection in Adults: A Scientific Statement From the American Heart Association. Stroke. 2024;55(3):e91-e106.
  8. Bhalla V et al. Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association. Hypertension. 2022;79(8):e128-e143.
  9. Aboyans V et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890-2909.
  10. Friedman DD et al. CT Angiography of the Upper Extremities: Review of Acute Arterial Entities. RadioGraphics. 2025;45(1):e240077.
  11. Mazzolai L et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. European Heart Journal. 2024;45(36):3538-3700.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.